Cargando…
Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Chang Gung University
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661506/ https://www.ncbi.nlm.nih.gov/pubmed/35065283 http://dx.doi.org/10.1016/j.bj.2022.01.012 |
| _version_ | 1784830492584968192 |
|---|---|
| author | Chen, Wei-Chun Chang, Ting-Chang Chou, Hung-Hsueh |
| author_facet | Chen, Wei-Chun Chang, Ting-Chang Chou, Hung-Hsueh |
| author_sort | Chen, Wei-Chun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9661506 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Chang Gung University |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96615062022-11-14 Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy Chen, Wei-Chun Chang, Ting-Chang Chou, Hung-Hsueh Biomed J Letter to the Editor Chang Gung University 2022-10 2022-01-19 /pmc/articles/PMC9661506/ /pubmed/35065283 http://dx.doi.org/10.1016/j.bj.2022.01.012 Text en © 2022 Chang Gung University. Publishing services by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letter to the Editor Chen, Wei-Chun Chang, Ting-Chang Chou, Hung-Hsueh Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy |
| title | Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy |
| title_full | Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy |
| title_fullStr | Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy |
| title_full_unstemmed | Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy |
| title_short | Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy |
| title_sort | reply: serum ca-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661506/ https://www.ncbi.nlm.nih.gov/pubmed/35065283 http://dx.doi.org/10.1016/j.bj.2022.01.012 |
| work_keys_str_mv | AT chenweichun replyserumca125andrenalimpairmentinpatientsundergoinghyperthermicintraperitonealchemotherapy AT changtingchang replyserumca125andrenalimpairmentinpatientsundergoinghyperthermicintraperitonealchemotherapy AT chouhunghsueh replyserumca125andrenalimpairmentinpatientsundergoinghyperthermicintraperitonealchemotherapy |